Etokimab

艾托奇单抗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEtokimab
Drug Alias NameANB-020
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin-33 inhibitors
TargetsInterleukin-33
Therapy Area/IndicationsPeanut HypersensitivityHypersensitivityDermatitis, Atopic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnaptysbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnaptysbio Inc
Inactive CompaniesN/A
Active IndicationsHypersensitivityAsthma
Inactive IndicationsPeanut HypersensitivityDermatitis, AtopicPulmonary Eosinophilia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A